NLS PHARMACEUTICS LTD -CW25 (NLSPW) Stock News

USA - NASDAQ:NLSPW -

0.025 USD

+0 (+24.38%)

Last: 10/17/2025, 8:00:01 PM

Technical Analysis

NLSPW Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: NLS Pharmaceutics Ltd. - Mentions: NLSP

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting

a month ago - By: NLS Pharmaceutics Ltd. - Mentions: NLSP

Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger

7 months ago - By: ACCESS Newswire - Mentions: NLSP

NLS Pharmaceutics and Kadimastem Announces Up to $3 Million Equity Financing and $25 Million Equity Facility Agreement

8 months ago - By: NLS Pharmaceutics Ltd. - Mentions: NLSP

News Image

NLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform

9 months ago - By: NLS Pharmaceutics Ltd. - Mentions: NLSP

News Image

NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting

9 months ago - By: NLS Pharmaceutics Ltd. - Mentions: NLSP

News Image

NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

11 months ago - By: NLS Pharmaceutics Ltd. - Mentions: NLSP

News Image

NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market

2 years ago - By: Benzinga - Mentions: NLSP

NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letter